ClinicalTrials.Veeva

Menu

Chlorhexidine Versus Povidone-Iodine Antisepsis for Reduction of Post Cesarean Section Surgical Site Infection

A

Ain Shams Maternity Hospital

Status and phase

Unknown
Phase 2

Conditions

Surgical Site Infection

Treatments

Drug: Povidone-Iodine
Drug: Chlorhexidine

Study type

Interventional

Funder types

Other

Identifiers

NCT02396329
antisepsis 1

Details and patient eligibility

About

There is no difference between using chlorhexidine-based antisepsis protocol versus povidone-iodine protocol in reduction of surgical site infection in women undergoing cesarean section.

Full description

The aim of this study is to examine the efficacy &safety of Chlorhexidine-based antisepsis protocol versus povidone- iodine protocol used as preoperative skin antisepsis for patients undergoing cesarean section in reduction of surgical site infection.Chlorhexidine is a chemical antiseptic. It is effective on both Gram-positive and Gram-negative bacteria, although it is less effective with some Gram-negative bacteria. It has both bactericidal and bacteriostatic mechanisms of action, the mechanism of action being membrane disruption.

Iodine is commonly used as an antiseptic agent clinically. Iodine is usually formulated as an iodophor, which consists of iodine combined with a carrier molecule. This formulation increases the solubility of iodine and provides a reservoir for sustained release. The most commonly used iodophor is povidone iodine which is a 10% iodophor solution that contains 1% available iodine. Iodine molecules penetrate microbial cell walls and cause oxidation of cysteine, iodination of amino acids and unsaturated fatty acids. This leads to reduced protein synthesis and bacterial cell wall damage.

Enrollment

410 estimated patients

Sex

Female

Ages

18 to 42 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patient 18 years of age or older who will undergo cesarean deliveries who are at term (37wks-41wks of gestation).
  2. Body mass index (BMI) between 20-35kg/m2.
  3. Able to communicate well with the investigator and to comply with the requirements of the entire study.

Exclusion criteria

  1. Rupture of membranes.
  2. Patients who have history of allergy to chlorhexidine, alcohol and iodophors.
  3. Documented concomitant infections like: Chorioamnionitis, Pyelonephritis, Urinary tract infection, Mastitis.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

410 participants in 2 patient groups

chlorhexidine _based antisepsis
Experimental group
Description:
Including cases undergoing elective\&non elective caesarean section.Patients will be were prepared similarly by three applications of 2%chlorhexidine solution time given between each application about 30 seconds followed by drying with a sterile towel and three applications of 70% alcohol after one minute The area scrubbed was from the xiphoid to the knee, reaching the midaxillary line laterally. In both groups, patients received preoperative prophylactic i.v antibiotics (cefotrixone 1 gm) one hour before skin incision. .
Treatment:
Drug: Chlorhexidine
povidone_iodine based antisepsis
Active Comparator group
Description:
Including cases undergoing elective\&nonelective caesarean section.Patients will be scrubbed preoperative with an applicator that contain 10%povidone-iodine scrub aqueous solution(3 consecutive applications)followed by drying with sterile towel and 3 application of 70% alcohol after one minute The area scrubbed was from the xiphoid to the knee, reaching the midaxillary line laterally. In both groups, patients received preoperative prophylactic i.v antibiotics (cefotrixone 1 gm) one hour before skin incision
Treatment:
Drug: Povidone-Iodine

Trial contacts and locations

1

Loading...

Central trial contact

AMR YEHIA, MD, MRCOG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems